Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Apr;79(7):2319–2322. doi: 10.1073/pnas.79.7.2319

Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells.

P A Barouski-Miller, T D Gelehrter
PMCID: PMC346184  PMID: 6179095

Abstract

Incubation of rat hepatoma cells with cAMP derivatives stimulates cell-associated plasminogen activator activity 8- to 22-fold and extracellular plasminogen activator activity 30- to 1300-fold. This time- and concentration-dependent increase is enhanced by phosphodiesterase inhibitors. Dexamethasone, a synthetic glucocorticoid, decreases the plasminogen activator activity of these cells, probably through induction of an inhibitor. Paradoxically, dexamethasone, added simultaneously with cAMP derivatives causes a further 4-fold enhancement of the cAMP-mediated stimulation of plasminogen activator activity. Dexamethasone also alters the time course of cAMP-mediated enhancement of plasminogen activator activity: increased protease activity is detected at 4 hr in cells incubated with 8-bromoadenosine-3':5'-cyclic monophosphoric acid and 1-methyl-3-isobutylxanthine but not until 12 hr in cells incubated with dexamethasone as well. Glucocorticoids thus exert two separate and opposite effects on plasminogen activator activity: induction of an inhibitor and amplification of cyclic nucleotide action. Although permissive and synergistic effects of dexamethasone on cyclic nucleotide action have been reported previously, glucocorticoid regulation of plasminogen activator activity is unique in that the amplification of cyclic nucleotide effects by dexamethasone opposes its regulatory action toward a specific enzyme.

Full text

PDF
2319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barouski P. A., Gelehrter T. D. Loss of glucocorticoid regulation of plasminogen activator activity in anucleate rat hepatoma cells. Biochem Biophys Res Commun. 1980 Oct 31;96(4):1540–1546. doi: 10.1016/0006-291x(80)91349-2. [DOI] [PubMed] [Google Scholar]
  2. Beers W. H., Strickland S., Reich E. Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell. 1975 Nov;6(3):387–394. doi: 10.1016/0092-8674(75)90188-9. [DOI] [PubMed] [Google Scholar]
  3. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  4. Gelehrter T. D. Glucocorticoids and the plasma membrane. Monogr Endocrinol. 1979;12:561–574. doi: 10.1007/978-3-642-81265-1_30. [DOI] [PubMed] [Google Scholar]
  5. Granelli-Piperno A., Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med. 1978 Jul 1;148(1):223–234. doi: 10.1084/jem.148.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Granelli-Piperno A., Vassalli J. D., Reich E. Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med. 1977 Dec 1;146(6):1693–1706. doi: 10.1084/jem.146.6.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Granner D. K. The role of glucocorticoid hormones as biological amplifiers. Monogr Endocrinol. 1979;12:593–611. doi: 10.1007/978-3-642-81265-1_33. [DOI] [PubMed] [Google Scholar]
  8. Grove J. R., Dieckmann B. S., Schroer T. A., Ringold G. M. Isolation of glucocorticoid-unresponsive rat hepatoma cells by fluorescence-activated cell sorting. Cell. 1980 Aug;21(1):47–56. doi: 10.1016/0092-8674(80)90113-0. [DOI] [PubMed] [Google Scholar]
  9. Hargrove J. L., Volentine G., Granner D. K. On the steroid requirement for induction of tyrosine aminotransferase by N6, O2'-dibutyryl cyclic AMP in hepatoma cells. J Steroid Biochem. 1981 Jan;14(1):101–108. doi: 10.1016/0022-4731(81)90198-9. [DOI] [PubMed] [Google Scholar]
  10. Kucherlapati R., Tepper R., Granelli-Piperno A., Reich E. Modulation and mapping of a human plasminogen activator by cell fusion. Cell. 1978 Dec;15(4):1331–1340. doi: 10.1016/0092-8674(78)90058-2. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Lacroix M., Smith F. E., Fritz I. B. Secretion of plasminogen activator by Sertoli cell enriched cultures. Mol Cell Endocrinol. 1977 Dec;9(2):227–236. doi: 10.1016/0303-7207(77)90124-1. [DOI] [PubMed] [Google Scholar]
  13. Laishes B. A., Roberts E., Burrowes C. Fibrinolytic activity of adult rat liver cells in primary culture and inhibition by glucocorticoids. Biochem Biophys Res Commun. 1976 Sep 20;72(2):462–471. doi: 10.1016/s0006-291x(76)80065-4. [DOI] [PubMed] [Google Scholar]
  14. Laug W. E., Jones P. A., Nye C. A., Benedict W. F. The effect of cyclic AMP and prostaglandins on the fibrinolytic activity of mouse neuroblastoma cells. Biochem Biophys Res Commun. 1976 Jan 12;68(1):114–119. doi: 10.1016/0006-291x(76)90017-6. [DOI] [PubMed] [Google Scholar]
  15. Linney E., Levinson B. B. Teratocarcinoma differentiation: plasminogen activator activity associated with embryoid body formation. Cell. 1977 Feb;10(2):297–304. doi: 10.1016/0092-8674(77)90223-9. [DOI] [PubMed] [Google Scholar]
  16. Miskin R., Easton T. G., Reich E. Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid. Cell. 1978 Dec;15(4):1301–1312. doi: 10.1016/0092-8674(78)90055-7. [DOI] [PubMed] [Google Scholar]
  17. Mott D. M., Fabisch P. H., Sorof S. Cyclic AMP phosphodiesterase inhibitors depress production of plasminogen activator by Chinese hamster ovary cells. Biochem Biophys Res Commun. 1976 Jun 21;70(4):1150–1156. doi: 10.1016/0006-291x(76)91023-8. [DOI] [PubMed] [Google Scholar]
  18. Roblin R., Young P. L. Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells. Cancer Res. 1980 Aug;40(8 Pt 1):2706–2713. [PubMed] [Google Scholar]
  19. Rosen N., Schneck J., Bloom B. R., Rosen O. M. Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line. J Cyclic Nucleotide Res. 1978 Oct;4(5):345–358. [PubMed] [Google Scholar]
  20. Rousseau G. G. Activity of protein kinase dependent on adenosine 3':5'-monophosphate and of its thermostable protein inhibitor in rat hepatoma (HTC) cells. Unlikely role in the permissive action of glucocorticoids. Eur J Biochem. 1977 Jun 1;76(1):309–316. doi: 10.1111/j.1432-1033.1977.tb11597.x. [DOI] [PubMed] [Google Scholar]
  21. Seifert S. C., Gelehrter T. D. Isolation of rat hepatoma cell variants selectively resistant to dexamethasone inhibition of plasminogen activator. J Cell Physiol. 1979 Jun;99(3):333–341. doi: 10.1002/jcp.1040990308. [DOI] [PubMed] [Google Scholar]
  22. Seifert S. C., Gelehrter T. D. Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6130–6133. doi: 10.1073/pnas.75.12.6130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shepro D., Schleef R., Hechtman H. B. Plasminogen activator activity by cultured bovine aortic endothelial cells. Life Sci. 1980 Feb 11;26(6):415–422. doi: 10.1016/0024-3205(80)90159-9. [DOI] [PubMed] [Google Scholar]
  24. Stellwagen R. H. Induction of tyrosine aminotransferase in HTC cells by N 6 , O 2' -dibutyryl adenosine 3', 5'-monophosphate. Biochem Biophys Res Commun. 1972 Jun 9;47(5):1144–1150. doi: 10.1016/0006-291x(72)90954-0. [DOI] [PubMed] [Google Scholar]
  25. Strickland S., Beers W. H. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem. 1976 Sep 25;251(18):5694–5702. [PubMed] [Google Scholar]
  26. Thompson E. B., Granner D. K., Gelehrter T., Erickson J., Hager G. L. Unlinked control of multiple glucocorticoid-induced processes in HTC cells. Mol Cell Endocrinol. 1979 Sep;15(3):135–150. doi: 10.1016/0303-7207(79)90034-0. [DOI] [PubMed] [Google Scholar]
  27. Thompson E. B., Tomkins G. M., Curran J. F. Induction of tyrosine alpha-ketoglutarate transaminase by steroid hormones in a newly established tissue culture cell line. Proc Natl Acad Sci U S A. 1966 Jul;56(1):296–303. doi: 10.1073/pnas.56.1.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976 Jun;8(2):271–281. doi: 10.1016/0092-8674(76)90011-8. [DOI] [PubMed] [Google Scholar]
  29. Werb Z. Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med. 1978 Jun 1;147(6):1695–1712. doi: 10.1084/jem.147.6.1695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Werb Z., Mainardi C. L., Vater C. A., Harris E. D., Jr Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med. 1977 May 5;296(18):1017–1023. doi: 10.1056/NEJM197705052961801. [DOI] [PubMed] [Google Scholar]
  31. Wilson E. L., Reich E. Modulation of plasminogen activator synthesis in chick embryo fibroblasts by cyclic nucleotides and phorobol myristate acetate. Cancer Res. 1979 May;39(5):1579–1586. [PubMed] [Google Scholar]
  32. van Rijn H., Bevers M. M., van Wijk R., Wicks W. D. Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. 3. Comparative studies in H35, HTC, MH1C1 and RLC cells. J Cell Biol. 1974 Jan;60(1):181–191. doi: 10.1083/jcb.60.1.181. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES